tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

DAWN Stock Latest News

3 Best Stocks to Buy Now, 6/18/2024, According to Top Analysts
Market News3 Best Stocks to Buy Now, 6/18/2024, According to Top Analysts
14d ago
CELH
DAWN
Day One Biopharmaceuticals Secures Major Cancer Drug Rights
PremiumCompany Announcements
Day One Biopharmaceuticals Secures Major Cancer Drug Rights
15d ago
8K
DAWN
Day One Biopharmaceuticals in pact with MabCare for MTX-13 targeting PTK7
PremiumThe Fly
Day One Biopharmaceuticals in pact with MabCare for MTX-13 targeting PTK7
15d ago
DAWN
Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers
PremiumPress Releases
Day One Expands Pipeline with Potential First-in-Class Clinical-Stage Antibody Drug Conjugate (ADC) Targeting PTK7 in Solid Tumors for Adult and Pediatric Cancers
15d ago
DAWN
Day One Biopharmaceuticals Updates FIREFLY-2 Trial Strategy
PremiumCompany Announcements
Day One Biopharmaceuticals Updates FIREFLY-2 Trial Strategy
21d ago
8K
DAWN
Xoma receives $8.1M milestone related to Day One’s sale of PRV
PremiumThe FlyXoma receives $8.1M milestone related to Day One’s sale of PRV
21d ago
DAWN
VIRX
Day One Biopharmaceuticals Capitalizes on Priority Review Sale
PremiumCompany Announcements
Day One Biopharmaceuticals Capitalizes on Priority Review Sale
1M ago
8K
DAWN
Day One Biopharmaceuticals announces sale of Priority Review Voucher for $108M
PremiumThe Fly
Day One Biopharmaceuticals announces sale of Priority Review Voucher for $108M
1M ago
DAWN
VIRX
Day One Announces Sale of Priority Review Voucher for $108 Million
PremiumPress Releases
Day One Announces Sale of Priority Review Voucher for $108 Million
1M ago
DAWN
BrightSpring Health announces Onco360 selected as partner for OJEMDA
PremiumThe Fly
BrightSpring Health announces Onco360 selected as partner for OJEMDA
1M ago
BTSG
DAWN
Day One price target lowered to $40 from $50 at H.C. Wainwright
PremiumThe Fly
Day One price target lowered to $40 from $50 at H.C. Wainwright
2M ago
DAWN
Day One Biopharmaceuticals reports Q1 EPS (72c), consensus (66c)
PremiumThe Fly
Day One Biopharmaceuticals reports Q1 EPS (72c), consensus (66c)
2M ago
DAWN
Day One Biopharmaceuticals Unveils Updated Corporate Presentation
PremiumCompany AnnouncementsDay One Biopharmaceuticals Unveils Updated Corporate Presentation
2M ago
8K
DAWN
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
PremiumPress Releases
Day One Reports First Quarter 2024 Financial Results and Corporate Progress
2M ago
DAWN
FDA Approval Gives Day One Biopharmaceuticals (NASDAQ:DAWN) More Room to Run
PremiumMarket News
FDA Approval Gives Day One Biopharmaceuticals (NASDAQ:DAWN) More Room to Run
2M ago
DAWN
JPMorgan biotech analysts to hold an analyst/industry conference call
PremiumThe Fly
JPMorgan biotech analysts to hold an analyst/industry conference call
2M ago
DAWN
Day One comments from call weighing on sentiment, says BofA
PremiumThe Fly
Day One comments from call weighing on sentiment, says BofA
2M ago
DAWN
Xoma earns $9M milestone as FDA grants approval of Day One’s NDA for OJEMDA
PremiumThe Fly
Xoma earns $9M milestone as FDA grants approval of Day One’s NDA for OJEMDA
2M ago
DAWN
XOMA
Day One Biopharmaceuticals Achieves FDA Approval and Rare Voucher
PremiumCompany Announcements
Day One Biopharmaceuticals Achieves FDA Approval and Rare Voucher
2M ago
8K
DAWN
Day One Biopharmaceuticals price target raised to $33 from $30 at Needham
PremiumThe FlyDay One Biopharmaceuticals price target raised to $33 from $30 at Needham
2M ago
DAWN
Day One should rally to $17.50-$18 on approval, says JonesResearch
PremiumThe Fly
Day One should rally to $17.50-$18 on approval, says JonesResearch
2M ago
DAWN
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
PremiumPress Releases
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor
2M ago
DAWN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >